Search
09/06/2022
Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure
Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.829490. PMID:35757319. IF:3.600(Q2/5D).
09/06/2022
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial
Perl, AE, Larson, RA, Podoltsev, NA, Strickland, S, Wang, ES, Atallah, E, Schiller, GJ, Martinelli, G, Neubauer, A, Sierra, J, Montesinos, P, Recher, C, Yoon, SS, Hosono, N, Onozawa, M, Chiba, S, Kim, HJ, Hasabou, N, Lu, QY, Tiu, R, Levis, MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. BLOOD. 2022; 139(23)DOI:10.1182/blood.2021011583. PMID:35081255. IF:20.300(Q1/1D).
03/06/2022
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K, Shah, Z, Chia, R, Scholz, SW, Alcolea, D., Clarimón, J., Fortea, J., Lleó, A., Int LBD Genomics Consortium. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. BRAIN. 2022; 145(5)DOI:10.1093/brain/awab402. PMID:35381062. IF:14.500(Q1/1D).
03/06/2022
Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis
Rivera, CM, Crespo-Lessman, A, Arismendi, E, Munoz-Esquerre, M, Aguilar, X, Ausin, P, Bobolea, I, Duch, GD, Teixido, RP, Talaverano, GS, Sabardia, AS, Gall, XM. Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis. JOURNAL OF ASTHMA. 2022; 59(6)DOI:10.1080/02770903.2021.1917605. PMID:33882776. IF:1.900(Q4/8D).
02/06/2022
A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Aracil-Bolanos, I, Horta-Barba, A, Puig-Davi, A, Pagonabarraga, J. A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.866502. PMID:35720066. IF:3.400(Q2/5D).
02/06/2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort
Tam, CS, Allan, JN, Siddiqi, T, Kipps, TJ, Jacobs, R, Opat, S, Barr, PM, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, BJ, Moreno, C, Szafer-Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, JP, Wierda, WG, Ghia, P. Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort. BLOOD. 2022; 139(22)DOI:10.1182/blood.2021014488. PMID:35196370. IF:20.300(Q1/1D).